SCHEMBL30730808

SCHEMBL30730808

CN(C)C(=O)c1cnc2c(c1)c(-c1cncc(-c3ccc(N4CCCC4=O)cc3)c1)c(C1CC1)n2C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 5/20 0.44
IP6K1 Q92551 1/20 0.37
IP6K3 Q96PC2 1/20 0.37
IP6K2 Q9UHH9 1/20 0.37
NPC1 O15118 4/20 0.36
CCNA2 P20248 4/20 0.36
CDK2 P24941 4/20 0.36
CCNA1 P78396 4/20 0.36
CCNB2 O95067 1/20 0.36
CCNE2 O96020 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
CHEK1 O14757 1/20 0.36
SYK P43405 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22553996 1.00 CYP11B2 (0.44) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22554055 0.89 CYP11B2 (0.46) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22553940 0.87 CYP11B2 (0.44) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22553743 0.83 CYP11B2 (0.42) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL30730843 0.83 CYP11B2 (0.42) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22554169 0.82 CYP11B2 (0.45) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22553785 0.82 CYP11B2 (0.45) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22553766 0.79 CYP11B2 (0.44) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22554215 0.77 CYP11B2 (0.42) CYP11B2IP6K1IP6K3IP6K2NPC1
SCHEMBL22553925 0.77 CYP11B2 (0.45) CYP11B2IP6K1IP6K3IP6K2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C CYP11B2 3643/4885IP6K1 22/4885IP6K3 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.